DIAT develops medical bed isolation system for Covid-19 patients

▴ diat-develops-aashray-medical-bed-isolation-system
Defence Institute of Advanced Technology develops medical bed isolation system named as "AASHRAY"

In the current pandemic, due to the continuous increase of COVID-19 positive patients, the requirement of the number of beds is increasing day by day.

Defense Institute of Advanced Technology, (DIAT) a Deemed to be University, Pune has developed Aashray (आश्रय), the Medical Bed Isolation System to combat COVID-19 by stopping/ minimizing the spread of virus/ infection released by the patient. This is a low cost, reusable solution to maintain proper isolation of COVID-19 patients by creating suction /negative pressure near exhale, and further filtering and disinfecting the aerosol.

Bed Isolation System envelopes are made up of specialized material and manufacturing process with transparent and translucent 7.5(l) ×7(w) ×6.5(h) ft3 size supported on medical grade materials structure. The product is modular and portable in design and can be suitable for different requirements such as institutional, hospitals and home/ individual quarantine. The envelope is reusable as it is antibacterial-antifungal and can be sanitized.

Each envelope is capable of housing one set of beds, table and chairs along with some walking space. The width of the envelope can be adjusted as per the availability of space. The envelope is opaque up to 3 ft from the bottom to maintain the privacy of the patient.

The entire envelope is maintained at a low pressure (suction) with an adjustable flow rate to restrain the spread of virus/ infection inside the hall/ ICU. Each envelope is connected to the main duct equipped with UV light and filter circuit of Pre, fine and HEPA filter (recommended for medical application) and suction blower. The cross-flow of air from the top of the envelope towards the main duct is regulated (with a flap valve) as per the comfort conditions of the patient. The virus/contaminants are continuously sucked through the duct and accumulated at the filters which are projected with UV light. The suction blower throws the filtered and contamination-free air to the outside environment.

As per prototype manufacturer (M/s Cleancore Solutions Pvt Ltd. Bhosari, Pune), the cost of the setup for a unit of 10 beds is 1.0 Lakhs approximately and for home, the quarantine will be 15,000/- (approx) for a single bed.

Tags : #DIAT #DefenceInstituteofAdvancedTechnology #Covid19patients #HepaFilters #UVLight

About the Author


Team Medicircle

Related Stories

04 May

Centre waives off IGST on import of Corona related medical supplies

To facilitate procurement government let go duty on Covid imports

View
30 Apr

Maharashtra health minister Rajesh Tope warns of 3rd wave of Covid-19

Maharashtra prepares for 3rd wave

View
24 Apr

Remdesivir – Antiviral drug for treatment of COVID 19

“Remdesivir has been helpful in treating the viral infection SARS - CoV 2, however, a combination of drug therapy that includes vitamin supplements, steroids, oxygen supply, blood thinner is being used to treat Covid-19 patients.”

View
20 Apr

Now all adults are eligible for vaccination: Central Government

Government opens up COVID-19 vaccination for all above 18 years of age from May 1

View
15 Apr

Centre approves increase in production of Remdesivir and reducing its prices

ED has been directed to act against black marketing of Remdesivir

View
12 Mar

Steps being taken to reduce difference between Selling price & actual price of Remdesivir injection: Maharashtra Minister

The difference in the selling price of Remdesivir from different outlets to be addressed

View
14 Jan

Bharat Bioech ships Covaxin to 11 cities

Covaxin the inactivated vaccine reaches India cities, though final trial reports are awaited

View
10 Nov

WHO-led COVID drug scheme doubles down on antibodies, steroids and shuns remdesivir

A World Health Organization-led scheme to supply COVID-19 drugs to poor countries is betting on experimental monoclonal antibody treatments and steroids and shuns remdesivir.

View
23 Oct

Gilead's remdesivir gets U.S. FDA approval for hospitalized COVID-19 patients

The U.S. Food and Drug Administration on Thursday approved Gilead Sciences Inc’s antiviral drug remdesivir for treating patients hospitalized with COVID-19

View
17 Oct

Remdesivir useless for severe Covid-19 patients : WHO

The search for effective drug continues for severely affected Covid patients

View

-Advertisements-




Trending Now

Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025
CARE Hospitals Launches AI-Powered Non-Invasive Therapy – An innovative modality introduced in Telangana & Andhra PradeshApril 02, 2025
High-Rise Heart Attacks: Are Skyscrapers Turning Survival into a Race Against Time?April 02, 2025
DCDC’s $150 Crore Expansion: Can Innovative Clinics End India's Kidney Crisis?April 02, 2025
Medanta Rolls Out ‘Colon Tunnel on Wheels’ to Drive Awareness on Colorectal Cancer Prevention & Early DetectionApril 01, 2025
Zigly launches 2 pet hospitals, opens 4 new stores; expects ARR to more than double in 1-2 yearsApril 01, 2025
University of Leeds Announces International Masters Regional Scholarships for 2025April 01, 2025
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025April 01, 2025
Foundation Stone Laid for Madhav Netralaya Eye Hospital & Research CentreApril 01, 2025
Doomscrolling at Midnight: How Indians Are Sacrificing Sleep for ScreensMarch 31, 2025
Essential Medicines Price Surge: Are Patients Paying the Price?March 31, 2025
Prioritize your health during the holy days of RamzanMarch 31, 2025
Tired of Stomach Cramps? These Simple Foods Can Heal Your GutMarch 31, 2025
Regional growth booming for startups in 2024 - QBO Innovation studyMarch 31, 2025
Is long-acting HIV treatment as good as taking daily pills?March 31, 2025
Right to safe abortion cannot be dislocated from human rightsMarch 28, 2025
Popeyes® Opens Third Store in Hyderabad at Inorbit MallMarch 28, 2025
Popeyes® Opens Third Store in Hyderabad at Inorbit MallMarch 28, 2025
10 New HIV Cases in 2 Months: Has Kerala’s Drug Problem Gone Too Far?March 28, 2025
Type 2 Diabetes Under Attack: The Unexpected Power of Wearable TechMarch 28, 2025